Stay updated with breaking news from Accelerate Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Antimicrobial Susceptibility Testing Market worth $4.2 billion by 2025 – Size, Industry Trends, Key Players and Forecast
.......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... TUCSON, Ariz. — Accelerate Diagnostics Inc. (AXDX) on Thursday reported a loss of $24.2 million in its first quarter. The Tucson, Arizona-based company said it had a loss of 41 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 33 cents per share. The maker of systems that diagnose dru...
Accelerate Diagnostics Reports First Quarter 2021 Financial Results News provided by Share this article Share this article TUCSON, Ariz., May 6, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2021. "First quarter financial results were consistent with our expectations," commented Jack Phillips, Chief Executive Officer of Accelerate Diagnostics, Inc. "We also progressed key commercial and product development programs during the quarter." First Quarter 2021 Highlights Added 2 contracted ...
Press release content from Business Wire. The AP news staff was not involved in its creation. Lumos Diagnostics Appoints Three Industry Leaders as Independent Directors May 5, 2021 GMT SARASOTA, Fla.--(BUSINESS WIRE)--May 5, 2021-- Lumos Diagnostics announced today the expansion of its board with the appointment of three new independent directors to support the continued growth of the company’s rapid point-of-care diagnostic products and services business. Bronwyn Le Grice, Lawrence Mehren and Catherine Robson will join Executive Chair Sam Lanyon and and Executive Director Rob Sambursky, MD...
Accelerate Diagnostics to Host Call to Review First Quarter 2021 Results News provided by Share this article Share this article TUCSON, Ariz., May 5, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) announced today that management will host a conference call on Thursday, May 6, 2021 at 4:30 p.m. Eastern Time to review 2021 first quarter financial results. To listen by phone, dial +1.877.883.0383 and enter Elite Entry Number: 4747452. International participants may dial +1.412.902.6506. Please dial in 10–15 minutes prior to the start of the conference. This conference call ...